Kidney Disease
Ascelia Pharma Meets Major Milestone with Patient Enrollment Completion of Phase 3 Study for Orviglance, Novel MRI Contrast Agent for Patients with Kidney Impairment
Ascelia Pharma
PR-M02-23-04Feb 27, 2023
Collaboration
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
Baxter
PR-M05-18-NI-025May 07, 2018